澳優(01717.HK)盈喜後股價三連漲 午後升幅擴至逾9.5%創半年高
澳優(01717.HK)自日前盈喜料全年多賺逾33%後,股價逆市連升第三天,今天跑贏乳業股,早段曾反覆回吐至11.62元拒絕再下,掉頭升破牛熊線(11.81元)後,有買盤跟進,午後曾高見12.88元,創逾半年高,現造12.82元,續漲9.6%,成交增至1,267萬股,涉資1.57億元。
澳優日前預計,去年純利按年增加33.6%-38.3%至8.48-8.78億元人民幣(下同),總營收升24%-25%至66.9億元。此外,大華繼顯日前也指,澳優看起來能經得起新冠肺炎疫情考驗,主因是公司83%工廠都位於中國以外地區,且鑒於嬰兒食品是日常必需品,這家配方奶粉製造商於中國工廠已獲准復工。該行又援引分銷商說法指,一些母親為防止潛在病毒傳播,不願母乳餵養,對配方奶粉需求因此增加,加上澳優給予一些商舖銷售回扣並支持產品送貨上門之舉,有望助其贏得市場份額。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.